Regulations.gov document
Tab B - "Substantive Changes and Changes in the Regulatory Action, May 3, 2010" - [OMB…
Supporting & Related Material · FDA-2009-N-0493 · posted May 5, 2010
Key facts
| Document ID | FDA-2009-N-0493-0004 |
|---|---|
| Title | Tab B - "Substantive Changes and Changes in the Regulatory Action, May 3, 2010" - [OMB Review, Executive Order 12866, Regulatory Policy Management Staff to the Division of Dockets Management, (Neurological and Physical Medicine Devices; Designation of Special Controls for Certain Class II Devices and Exemption From Premarket Notification, Proposed Rule, April 5, 2010)] |
| Document type | Supporting & Related Material |
| Subtype | REF-Reference (internal unless indicated) |
| Agency | FDA |
| Docket | FDA-2009-N-0493 |
| Posted | May 5, 2010 |
| Effective date | May 3, 2010 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: